Cargando…

National action plan for non-communicable diseases prevention and control in Iran; a response to emerging epidemic

Emerging Non-communicable diseases burden move United Nation to call for 25% reduction by 2025 in premature mortality from non-communicable diseases (NCDs). The World Health Organization (WHO) developed global action plan for prevention and control NCDs, but the countries’ contexts, priorities, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peykari, Niloofar, Hashemi, Hassan, Dinarvand, Rasoul, Haji-Aghajani, Mohammad, Malekzadeh, Reza, Sadrolsadat, Ali, Sayyari, Ali Akbar, Asadi-lari, Mohsen, Delavari, Alireza, Farzadfar, Farshad, Haghdoost, Aliakbar, Heshmat, Ramin, Jamshidi, Hamidreza, Kalantari, Naser, Koosha, Ahmad, Takian, Amirhossein, Larijani, Bagher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260033/ https://www.ncbi.nlm.nih.gov/pubmed/28127543 http://dx.doi.org/10.1186/s40200-017-0288-4

Ejemplares similares

Scientometric Study on Non-communicable Diseases in Iran: A Review Article
por: PEYKARI, Niloofar, et al.
Publicado: (2018)

Inequality of obesity and socioeconomic factors in Iran: a systematic review and meta- analyses
por: Djalalinia, Shirin, et al.
Publicado: (2015)

Socioeconomic inequalities and diabetes: A systematic review from Iran
por: Peykari, Niloofar, et al.
Publicado: (2015)

Obesity Researches Over the Past 24 years: A Scientometrics Study in Middle East Countries
por: Djalalinia, Shirin, et al.
Publicado: (2015)

Diabetes research in Middle East countries; a scientometrics study from 1990 to 2012
por: Peykari, Niloofar, et al.
Publicado: (2015)

Policy Implications for Diabetes Prevention and Control: An Experience from Iran
por: Peykari, Niloofar, et al.
Publicado: (2022)

Non-communicable Diseases and COVID-19; a double-edged sword A Special Communication from IRAN
por: Peykari, Niloofar, et al.
Publicado: (2020)

Trend and projection of mortality rate due to non-communicable diseases in Iran: A modeling study
por: Khosravi Shadmani, Fatemeh, et al.
Publicado: (2019)

A Systematic Review on the Prevalence of Overweight and Obesity, in Iranian Children and Adolescents
por: Djalalinia, Shirin, et al.
Publicado: (2016)

Mortality Attributable to Excess Body Mass Index in Iran: Implementation of the Comparative Risk Assessment Methodology
por: Djalalinia, Shirin, et al.
Publicado: (2015)

High Fasting Plasma Glucose Mortality Effect: A Comparative Risk Assessment in 25–64 Years Old Iranian Population
por: Peykari, Niloofar, et al.
Publicado: (2016)

Editorial: Reducing the Burden of Age-Related Disease in Relation to Osteoporosis, Sarcopenia and Osteosarcopenia
por: Tabatabaei-Malazy, Ozra, et al.
Publicado: (2022)

Insulin pen use and diabetes treatment goals: A study from Iran STEPS 2016 survey
por: Ebrahimi, Hedyeh, et al.
Publicado: (2019)

Iran to achieve the SDG 3.4 at national and sub-national levels
por: Haghdoost, Ali Akbar, et al.
Publicado: (2022)

Application of discrete choice experiments to estimate value of life: a national study protocol in Iran
por: Mirzaee, Negar, et al.
Publicado: (2021)

Liver cirrhosis mortality at national and provincial levels in Iran between 1990 and 2015: A meta regression analysis
por: Rezaei, Negar, et al.
Publicado: (2019)

The Relationships between Social Capital, Metabolic, and Behavioral Risk Factors of Non-Communicable Diseases: A Systematic Review
por: Kiani, Mohammad Mehdi, et al.
Publicado: (2023)

Social determinants of health inequity in Iran: a narrative review
por: Rezaei, Negar, et al.
Publicado: (2022)

Inequality in prevalence, awareness, treatment, and control of hypertension in Iran: the analysis of national households’ data
por: Mahdavi, Mahdi, et al.
Publicado: (2022)

Prevalence of Non-Engineered Buildings and Population at Risk for a Probable Earthquake: A Cross-Sectional Study from an Informal Settlement in Tehran, Iran
por: FATHOLLAHI, Soraya, et al.
Publicado: (2020)

Impact of rural family physician program on child mortality rates in Iran: a time-series study
por: Naderimagham, Shohreh, et al.
Publicado: (2017)

Predictive factors of diabetic complications: a possible link between family history of diabetes and diabetic retinopathy
por: Maghbooli, Zhila, et al.
Publicado: (2014)

Assessment and prioritization of the WHO “best buys” and other recommended interventions for the prevention and control of non-communicable diseases in Iran
por: Bakhtiari, Ahad, et al.
Publicado: (2020)

Spatio-Temporal Analysis of the Hepatitis B Prevalence in Iranian Blood Donors from 2000 to 2016 at National and Provincial Level
por: Rezaei, Negar, et al.
Publicado: (2021)

Short and Long-term Impacts of COVID-19 Pandemic on Health Equity: A Comprehensive Review
por: Mohamadi, Efat, et al.
Publicado: (2022)

Trends of Diabetes Mortality in Iran at National and Sub-National Levels from 1990 to 2015 and Its Association with Socioeconomic Factors
por: Peykari, Niloofar, et al.
Publicado: (2022)

Premature mortality of gastrointestinal cancer in Iran: trends and projections 2001–2030
por: Shadmani, Fatemeh Khosravi, et al.
Publicado: (2020)

Burden of thyroid cancer in North Africa and Middle East 1990–2019
por: Nejadghaderi, Seyed Aria, et al.
Publicado: (2022)

Twenty-Six-Year Trend of Mortality Rate Due to Ischemic Heart Diseases (IHDs) in Iran: 1990–2015
por: Naderimagham, Shohreh, et al.
Publicado: (2022)

Level and trend of total plasma cholesterol in national and subnational of Iran: a systematic review and age-spatio-temporal analysis from 1990 to 2016
por: Mehdipour, Parinaz, et al.
Publicado: (2022)

The Burden of Cardiovascular Disease Attributable to Modifiable Risk Factors and Cost-effectiveness Analysis of IraPEN Program in the General Population of Iran
por: Mokhtari, Mehdi, et al.
Publicado: (2022)

Post COVID-19 neuropsychiatric complications and therapeutic role for TNF-α inhibitors: a case series study
por: Shafiee, Gita, et al.
Publicado: (2022)

Iran COVID-19 Epidemiology Committee: A Review of Missions, Structures, Achievements, and Challenges
por: Amiri, Shahin, et al.
Publicado: (2021)

Inequalities in the prevalence, diagnosis awareness, treatment coverage and effective control of diabetes: a small area estimation analysis in Iran
por: Perseh, Lida, et al.
Publicado: (2023)

Appendicular Skeletal Muscle Mass Reference Values and the Peak Muscle Mass to Identify Sarcopenia among Iranian Healthy Population
por: Shafiee, Gita, et al.
Publicado: (2018)

A nationwide study of metabolic syndrome prevalence in Iran; a comparative analysis of six definitions
por: Tabatabaei-Malazy, Ozra, et al.
Publicado: (2021)

A Report on Statistics of an Online Self-screening Platform for COVID-19 and Its Effectiveness in Iran
por: Azadnajafabad, Sina, et al.
Publicado: (2021)

Circulating cell-free nucleic acids as potential biomarkers for sarcopenia: a step toward personalized medicine
por: Shafiee, Gita, et al.
Publicado: (2017)

Total plasma homocysteine, folate, and vitamin b12 status in healthy Iranian adults: the Tehran homocysteine survey (2003–2004)/a cross – sectional population based study
por: Fakhrzadeh, Hossein, et al.
Publicado: (2006)

Patterns of the Social Approach to Health in Selected Countries and Iran: A Comparative Study
por: Asadi louyeh, Ataollah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cecpv7sepbr1ecopb70mgqj4rd